Gunderson Dettmer represented RadioMedix on the deal. RadioMedix announced its $40 million equity financing led by Portland Investment Counsel Inc. RadioMedix is a clinical-stage biotech focused ontargeted radiopharmaceuticals...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here